Jonathan Biller is Chief Financial Officer of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 22,953 shares of AGIO, which is worth approximately $784,763. The most recent transaction as insider was on Feb 22, 2022, when has been sold 2,688 shares (Common Stock) at a price of $29.08 per share, resulting in proceeds of $78,167. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23K
0% 3M change
0% 12M change
Total Value Held $784,763

Jonathan Biller Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 22 2022
SELL
Payment of exercise price or tax liability
$78,167 $29.08 p/Share
2,688 Reduced 10.48%
22,953 Common Stock
Feb 18 2022
BUY
Exercise of conversion of derivative security
-
8,523 Added 24.95%
25,641 Common Stock
Feb 10 2022
SELL
Payment of exercise price or tax liability
$42,399 $31.43 p/Share
1,349 Reduced 7.3%
17,118 Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
-
3,667 Added 16.57%
18,467 Common Stock
Dec 03 2021
SELL
Payment of exercise price or tax liability
$65,409 $35.88 p/Share
1,823 Reduced 10.97%
14,800 Common Stock
Dec 03 2021
BUY
Exercise of conversion of derivative security
-
5,753 Added 25.71%
16,623 Common Stock
Dec 03 2020
SELL
Payment of exercise price or tax liability
$78,300 $45.87 p/Share
1,707 Reduced 14.53%
10,040 Common Stock
Dec 03 2020
BUY
Exercise of conversion of derivative security
-
5,753 Added 32.87%
11,747 Common Stock

Also insider at

VRTX
VERTEX PHARMACEUTICALS INC Healthcare
JB

Jonathan Biller

Chief Financial Officer
Boston, MA

Track Institutional and Insider Activities on AGIO

Follow AGIOS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Track Activities on AGIO